Malaria bigger killer than previously thought
03 February, 2012 by Tim DeanA new study found more than 1.2 million people died from malaria in 2010, although the disease is on the decline thanks to new treatments.
US biosecurity board speaks out on H5N1 concerns
01 February, 2012 by Tim DeanThe US National Science Advisory Board for Biosecurity has explained in detail its rationale in requesting two papers dealing with highly pathogenic H5N1.
Pumping iron raises prospect Parkinson’s and Alzheimer's treatment
30 January, 2012 by Tim DeanResearchers have found a drug that removes excess iron from the brain can prevent Parkinson’s and Alzheimer's disease in mice, raising the prospect of a new treatment.
New skin cancer detection tool approved in Australia
25 January, 2012 by Dylan Bushell-EmblingCanada's Verisante Technology has been cleared by the TGA to sell its instant skin cancer detection tool in Australia.
Epigenetic markers point towards ovarian cancer diagnostic
24 January, 2012 by Tim DeanThe discovery of new epigenetic markers present in a majority of ovarian cancers could lead to improved early diagnosis of the deadly disease.
Malaria decloaked
23 January, 2012 by Staff WritersResearchers at the Walter and Eliza Hall Institute have identified a molecule that helps the malaria virus hide from the immune system.
Research on deadly H5N1 influenza strain halted
23 January, 2012 by Tim DeanScientists working on a highly pathogenic avian influenza H5N1 virus have voluntarily called a 60-day moratorium on their research to give governments and organisations time to prepare for their results.
Feature: Epigenetic mischief makers
28 December, 2011 by Graeme O'NeillDr Fatima Valdés-Mora has added yet another epigenetic mechanism to the growing list that allow cancers to run amok.
Science and censorship: the deadly H5N1 paper debate
21 December, 2011 by Tim DeanScientists have reacted with consternation to news that key details will be removed from a paper outlining a new mutant and potentially deadly H5N1 virus.
Diabetes: one size doesn’t fit all
30 November, 2011 by Staff WritersThe Garvan's Professor David James challenges many assumptions about diabetes, its causes and treatments, including whether obesity is always a bad thing.
Moles, eye colour and the genetics of skin cancer
14 November, 2011 by Tim DeanA new study has identified that a gene variation associated with a greater number of moles and non-blue eye colour is linked to an increased risk of melanoma.
Tackling breast cancer requires national coordination: report
11 November, 2011 by Staff WritersA new report by the Economist Intelligence Unit says "fragmentation" of research, funding and treatment of breast cancer is hampering Australia's response to the disease.
Feature: New pathways for cancer therapy
08 November, 2011 by Fiona WylieAssociate Professor Stuart Pitson has been delving into the world of sphingolipid-mediated cell signalling pathways, particularly their enticing possibilities in cancer treatment.
Protein microarray uncovers malaria immunity
03 November, 2011 by Staff WritersResearchers at the Walter and Eliza Hall institute have revealed some enticing information about how people develop immunity to malaria, opening the door to possible diagnostics and therapies.
Ramaciotti Awards Slideshow
28 October, 2011 by Staff WritersThe Ramaciotti Foundations are collectively one of the largest private contributors to biomedical research in Australia, and having recently celebrated their 40th anniversary, have granted more than $51 million to research projects since 1970. Last week saw the latest slew of awards and grants issued, with more than $2.6 million issued to biomedical researchers around the nation.
